病例研究观察性研究:急性低氧性呼吸衰竭COVID-19患者支气管上皮衬液中的炎性细胞因子
本研究在27例重症COVID-19相关急性低氧性呼吸衰竭患者插管后经气管导管用支气管微量采样法采集支气管上皮衬液(ELF)和血浆,全面检测25种细胞因子浓度。与健康志愿者相比,患者ELF中IL-6(中位数27.6 pmol/L)、IL-8(1045.1 pmol/L)、IL-17A(0.8 pmol/L)、IL-25(1.5 pmol/L)、IL-31(42.3 pmol/L)浓度显著升高,血浆中MCP-1和MIP-1β显著升高。ELF/血浆比值以IL-8最高(中位数737),IL-6(218)、IL-1β(202)、IL-31(169)、MCP-1(81)、MIP-1β(55)、TNF-α(47)较低。作者认为肺内炎症高度区隔化,全面分析ELF细胞因子是理解重症肺炎肺内炎症与全身相互作用的可行方法。
要点
- 27例重症COVID-19急性低氧性呼吸衰竭患者插管后经气管导管行支气管微量采样获取ELF,检测25种细胞因子。
- 与健康志愿者相比,患者ELF中IL-6(中位数27.6 pmol/L)、IL-8(1045.1 pmol/L)、IL-17A(0.8 pmol/L)、IL-25(1.5 pmol/L)、IL-31(42.3 pmol/L)显著升高。
- 患者血浆中MCP-1和MIP-1β浓度显著高于健康志愿者。
- 25种细胞因子中ELF/血浆比值以IL-8最高(中位数737),IL-6为218、IL-1β为202、IL-31为169、MCP-1为81、MIP-1β为55、TNF-α为47。
- 作者认为肺内炎症高度区隔化,全面分析ELF细胞因子是理解重症肺炎肺内炎症与全身相互作用的可行方法。
适用人群与场景
- 继发于重症COVID-19的急性低氧性呼吸衰竭患者,插管接受机械通气后采集标本。
处置流程与药物剂量
- 插管后立即经气管导管采用支气管微量采样法采集支气管上皮衬液(ELF),同时采集血浆,检测25种细胞因子浓度。
研究设计与关键结果
- 病例研究观察性研究,纳入27例COVID-19急性低氧性呼吸衰竭患者,经气管导管行支气管微量采样获取ELF并同步采集血浆,检测25种细胞因子。
- 与健康志愿者相比,患者ELF中IL-6(中位数27.6 pmol/L)、IL-8(1045.1 pmol/L)、IL-17A(0.8 pmol/L)、IL-25(1.5 pmol/L)、IL-31(42.3 pmol/L)浓度显著升高。
- 与健康志愿者相比,患者血浆中MCP-1和MIP-1β浓度显著升高。
- 25种细胞因子中ELF/血浆比值以IL-8最高(中位数737),IL-6为218、IL-1β为202、IL-31为169、MCP-1为81、MIP-1β为55、TNF-α为47。
证据类型、等级与局限
- 病例研究观察性研究;作者认为肺内炎症高度区隔化,全面分析ELF细胞因子是理解重症肺炎肺内炎症与全身相互作用的可行方法。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,全面分析ELF细胞因子是理解重症肺炎患者肺内炎症与全身相互作用的可行方法。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In this study, the concentrations of inflammatory cytokines were measured in the bronchial epithelial lining fluid (ELF) and plasma in patients with acute hypoxemic respiratory failure (AHRF) secondary to severe coronavirus disease 2019 (COVID-19).
METHODS: We comprehensively analyzed the concentrations of 25 cytokines in the ELF and plasma of 27 COVID-19 AHRF patients. ELF was collected using the bronchial microsampling method through an endotracheal tube just after patients were intubated for mechanical ventilation.
RESULTS: Compared with those in healthy volunteers, the concentrations of interleukin (IL)-6 (median 27.6 pmol/L), IL-8 (1045.1 pmol/L), IL-17A (0.8 pmol/L), IL-25 (1.5 pmol/L), and IL-31 (42.3 pmol/L) were significantly greater in the ELF of COVID-19 patients than in that of volunteers. The concentrations of MCP-1 and MIP-1β were significantly greater in the plasma of COVID-19 patients than in that of volunteers. The ELF/plasma ratio of IL-8 was the highest among the 25 cytokines, with a median of 737, and the ELF/plasma ratio of IL-6 (median: 218), IL-1β (202), IL-31 (169), MCP-1 (81), MIP-1β (55), and TNF-α (47) were lower.
CONCLUSIONS: The ELF concentrations of IL-6, IL-8, IL-17A, IL-25, and IL-31 were significantly increased in COVID-19 patients. Although high levels of MIP-1 and MIP-1β were also detected in the blood samples collected simultaneously with the ELF samples, the results indicated that lung inflammation was highly compartmentalized. Our study demonstrated that a comprehensive analysis of cytokines in the ELF is a feasible approach for understanding lung inflammation and systemic interactions in patients with severe pneumonia.
参考来源
- Sudo K, Kinoshita M, Kawaguchi K, et al. Case study observational research: inflammatory cytokines in the bronchial epithelial lining fluid of COVID-19 patients with acute hypoxemic respiratory failure. Crit Care. 2024. PMID: 38654351. doi:10.1186/s13054-024-04921-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。